You have 9 free searches left this month | for more free features.

Best Support Care (BSC)

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pancreatic Cancer Trial in Shanghai (K-001, )

Unknown status
  • Pancreatic Cancer
  • Shanghai, Shanghai, China
    RenJiH
Nov 9, 2020

Gastric Adenocarcinoma, Pancreatic Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (CT041 autologous CAR T-cell

Recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • CT041 autologous CAR T-cell injection
  • Physician's Choice(Paclitaxel or Irinotecan or Apatinib or Anti-PD-1 antibody)
  • Hefei, Anhui, China
  • +9 more
Feb 13, 2022

MDS Trial in Worldwide (Oral Azacitidine, Placebo for Oral Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Oral Azacitidine
  • Placebo for Oral Azacitidine
  • Buenos Aires, Argentina
  • +1 more
Aug 1, 2022

SARS-CoV 2, COVID-19, Coronavirus Disease 2019 Trial in France (Masitinib, Isoquercetin, Best Supportive Care)

Recruiting
  • SARS-CoV 2
  • +2 more
  • Aix-en-Provence, France
  • +5 more
Jun 20, 2022

Advanced Lung Carcinoma, Stage III Lung Cancer AJCC v8, Stage IV Lung Cancer AJCC v8 Trial in Jacksonville (Best Practice,

Recruiting
  • Advanced Lung Carcinoma
  • +2 more
  • Best Practice
  • +3 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Dec 6, 2022

COVID-19, Infections, Morality Trial in Fuzhou (Medical observation, Supportive treatment (BSC), Intensive care management)

Recruiting
  • COVID-19
  • +3 more
  • Medical observation
  • +2 more
  • Fuzhou, Fujian, China
    The 900th Hospital of the Joint Logistic Support Force, PLA
Jan 7, 2023

Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Houston (Best Practice, Educational Intervention,

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • Recurrent Malignant Solid Neoplasm
  • Best Practice
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Mast Cell Activation Syndrome Trial in Weldon Spring, Toulouse (Masitinib 4.5 mg/kg/day, Placebo, Best supportive care)

Recruiting
  • Mast Cell Activation Syndrome
  • Masitinib 4.5 mg/kg/day
  • +3 more
  • Weldon Spring, Missouri
  • +1 more
Jul 18, 2022

Platinum-sensitive Ovarian Cancer, Relapsed Ovarian Cancer Trial in France (OSE2101, Pembrolizumab 25 MG/ML [Keytruda])

Recruiting
  • Platinum-sensitive Ovarian Cancer
  • Relapsed Ovarian Cancer
  • OSE2101
  • Pembrolizumab 25 MG/ML [Keytruda]
  • Angers, France
  • +27 more
Jul 25, 2022

Carcinoma, Hepatocellular Trial in Worldwide (biological, drug, other)

Active, not recruiting
  • Carcinoma, Hepatocellular
  • pembrolizumab
  • +2 more
  • Hefei, Anhui, China
  • +40 more
Mar 3, 2022

Metastatic Prostate Carcinoma, Stage III Prostate Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8 Trial (Patient Navigation,

Not yet recruiting
  • Metastatic Prostate Carcinoma
  • +2 more
  • Patient Navigation
  • +3 more
  • (no location specified)
Aug 2, 2022

Urothelial Cancer Trial in Worldwide (Avelumab, Best Supportive Care, Following the planned interim analysis for this study:

Active, not recruiting
  • Urothelial Cancer
  • Avelumab
  • +2 more
  • Aurora, Colorado
  • +370 more
Oct 24, 2022

Colorectal Carcinoma Trial in Los Angeles (Best Practice, Consultation, Educational Intervention)

Recruiting
  • Colorectal Carcinoma
  • Best Practice
  • +8 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Oct 13, 2023

Colorectal Cancer Trial in China (fruquintinib, )

Completed
  • Colorectal Cancer
  • Hefei, Anhui, China
  • +14 more
Feb 13, 2020

Palliative Care, Kidney Failure, Chronic, Decision Making Trial in United States (Best Case/Worst Case communication tool

Enrolling by invitation
  • Palliative Care
  • +13 more
  • Best Case/Worst Case communication tool training
  • Denver, Colorado
  • +9 more
Jul 21, 2022

Acute Myeloid Leukemia (AML), Cancer Trial in Worldwide (Venetoclax, Azacitidine, Best Supportive Care (BSC))

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Cancer
  • Scottsdale, Arizona
  • +169 more
Aug 23, 2022

Ovarian Cancer, Fallopian Tube Adenocarcinoma, Fallopian Tube Carcinosarcoma Trial in Seattle (Exercise Counseling, Aerobic

Terminated
  • Ovarian Cancer
  • +21 more
  • Exercise Counseling
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 6, 2022

Anemia Trial in Worldwide (biological, drug, other)

Recruiting
  • Anemia
  • Luspatercept
  • +2 more
  • Halifax, Nova Scotia, Canada
  • +11 more
Jan 3, 2023

MDS, CMML Trial in Florence (CC-486)

Recruiting
  • MDS
  • CMML
  • Florence, Italy
    AOU Careggi- University of Florence
Mar 16, 2021

Nasopharyngeal Carcinoma Trial in Guangzhou (capecitabine, Best supportive care (BSC))

Completed
  • Nasopharyngeal Carcinoma
  • Guangzhou, Guangdong, China
    SunYat-senU
Jul 30, 2020

Thalassemia Trial in Worldwide (Luspatercept, Placebo, Best Supportive Care (BSC))

Active, not recruiting
  • Thalassemia
  • Los Angeles, California
  • +16 more
Aug 16, 2022

Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker

Active, not recruiting
  • Acute Myeloid Leukemia
  • +66 more
  • Best Practice
  • +3 more
  • Fullerton, California
    Virginia K Crosson Cancer Center
Jan 31, 2022

Thrombotic Microangiopathy Trial in Worldwide (Ravulizumab, Placebo, Best supportive care)

Recruiting
  • Thrombotic Microangiopathy
  • Ravulizumab
  • +2 more
  • Tampa, Florida
  • +90 more
Jan 26, 2023

Indolent Systemic Mastocytosis, Monoclonal Mast Cell Activation Syndrome Trial in Worldwide (BLU-263, Placebo)

Recruiting
  • Indolent Systemic Mastocytosis
  • Monoclonal Mast Cell Activation Syndrome
  • Palo Alto, California
  • +33 more
Jul 27, 2022

Feasibility of Best Supportive Care Delivery Trial (Best Supportive Care Checklist)

Completed
  • Feasibility of Best Supportive Care Delivery
  • Best Supportive Care Checklist
  • (no location specified)
Feb 27, 2020